ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693636 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693636; 2) Community: the network communities that were significantly associated with the response to NSC 693636; 3) Molecule: the relationships between components within communities and NSC 693636; 4) MDR: the compounds that were significantly associated with the NSC 693636.

NSC Compound Enrichment Correlation
NSC 722864 Null 0.0386895225700407 -0.040731512
NSC 728090 6-[3-(4-Aminopiperidine)-1-propyl]-5,6-dihydro-2,3-dimethoxy -8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0386895225700407 0.0563914
NSC 743399 Null 0.0386895225700407 0.11811881
NSC 743430 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0386895225700407 -0.028921609
NSC 751548 Fluka catalog #46729 0.0386895225700407 -0.0028510119
NSC 758230 Floxuridine (USAN) 0.0386895225700407 0.15374543
NSC 761676 Null 0.0386895225700407 0.054039961
NSC 764039 AZD-5363 0.0386895225700407 -0.25578073
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0386895225700407 0.36321185
NSC 140380 Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) 0.0386895225700413 0.15168928
Total:76  Current:50    [First] [Prev] [Next] [Last]